We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

48 hedge funds and large institutions have $116M invested in Voyager Therapeutics in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 7

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

35% more capital invested

Capital invested by funds: $86.5M → $116M (+$29.9M)

12% more funds holding

Funds holding: 43 → 48 (+5)

Holders
48
Holders Change
+5
Holders Change %
+11.63%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
28
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$5.41M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.58M
3
JP Morgan Chase
JP Morgan Chase
New York
+$2.23M
4
BFA
BlackRock Fund Advisors
California
+$1.91M
5
State Street
State Street
Massachusetts
+$1.04M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$10.2M
2
Goldman Sachs
Goldman Sachs
New York
-$1.33M
3
JHIU
Janus Henderson Investors US
Colorado
-$514K
4
CC
Casdin Capital
New York
-$206K
5
USAA
United Services Automobile Association
Texas
-$168K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$270K +$148K +12,123 +97%
TA
27
Teachers Advisors
New York
$206K +$158K +12,895 +220%
Wells Fargo
28
Wells Fargo
California
$199K +$202K +16,500 +996%
BG
29
BlackRock Group
United Kingdom
$158K +$176K +14,401 New
SO
30
STRS Ohio
Ohio
$131K +$124K +10,100 +532%
Manulife (Manufacturers Life Insurance)
31
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$103K +$79.6K +6,508 +227%
NFA
32
Nationwide Fund Advisors
Ohio
$82K +$50K +4,088 +121%
AIG
33
American International Group
New York
$74.3K +$41.5K +3,395 +101%
BlackRock
34
BlackRock
New York
$65K +$71.4K +5,839 +6,635%
BA
35
BlackRock Advisors
Delaware
$60K +$43K +3,512 +179%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$56K +$61.9K +5,060 New
Bank of America
37
Bank of America
North Carolina
$50K +$50K +4,083 +888%
AIM
38
Acrospire Investment Management
Illinois
$45K +$50.2K +4,106 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$32K – – –
PCM
40
Prelude Capital Management
New York
$24K +$26.2K +2,143 New
Legal & General Group
41
Legal & General Group
United Kingdom
$23K +$26.2K +2,141 New
Acadian Asset Management
42
Acadian Asset Management
Massachusetts
$20K +$6.8K +556 +46%
Deutsche Bank
43
Deutsche Bank
Germany
$19K +$11.3K +924 +106%
Citigroup
44
Citigroup
New York
$13K -$42.9K -3,510 -75%
BJ
45
BlackRock Japan
Japan
$11K +$12.7K +1,042 New
PA
46
Perceptive Advisors
New York
$7K +$7.95K +650 New
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$6.22K +$5.78K +472 +502%
Morgan Stanley
48
Morgan Stanley
New York
$1K -$8.96K -732 -88%
USAA
49
United Services Automobile Association
Texas
– -$168K -19,200 Closed
TRCT
50
Tower Research Capital (TRC)
New York
– -$30K -3,450 Closed
1
2
3

VYGR Hedge Fund Activity: Q2 2016 in Review

48 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q2 2016, worth a combined $116M — up 35% from $86.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VYGR positions and 4 closed out — a net gain of 5 holders — while 28 added to existing stakes and 7 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $5.41M. The largest seller was Wellington Management Group, cutting an estimated $10.2M.

  • 48 institutional investors held Voyager Therapeutics (VYGR) as of Q2 2016, up from 43 in Q1 2016.
  • Funds reported $116M of Voyager Therapeutics stock for Q2 2016, up 35% quarter-over-quarter.
  • 9 funds opened new Voyager Therapeutics positions in Q2 2016 and 4 closed out, a net change of +5 holders.
  • The largest Voyager Therapeutics buyer in Q2 2016 was PFM Health Sciences, an estimated $5.41M added.
  • The largest Voyager Therapeutics seller in Q2 2016 was Wellington Management Group, an estimated $10.2M sold.

Based on aggregated 13F filings for Q2 2016.